These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9639524)

  • 1. Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells.
    Döbbeling U; Dummer R; Laine E; Potoczna N; Qin JZ; Burg G
    Blood; 1998 Jul; 92(1):252-8. PubMed ID: 9639524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costimulation of cutaneous T-cell lymphoma cells by interleukin-7 and interleukin-2: potential autocrine or paracrine effectors in the Sézary syndrome.
    Foss FM; Koc Y; Stetler-Stevenson MA; Nguyen DT; O'Brien MC; Turner R; Sausville EA
    J Clin Oncol; 1994 Feb; 12(2):326-35. PubMed ID: 8113839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-15 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
    Leroy S; Dubois S; Tenaud I; Chebassier N; Godard A; Jacques Y; Dréno B
    Br J Dermatol; 2001 May; 144(5):1016-23. PubMed ID: 11359391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine IL-21 stimulation is involved in the maintenance of constitutive STAT3 activation in Sézary syndrome.
    van der Fits L; Out-Luiting JJ; van Leeuwen MA; Samsom JN; Willemze R; Tensen CP; Vermeer MH
    J Invest Dermatol; 2012 Feb; 132(2):440-7. PubMed ID: 21938013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome).
    Cirée A; Michel L; Camilleri-Bröet S; Jean Louis F; Oster M; Flageul B; Senet P; Fossiez F; Fridman WH; Bachelez H; Tartour E
    Int J Cancer; 2004 Oct; 112(1):113-20. PubMed ID: 15305382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
    Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
    Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-7 mRNA is not overexpressed in mycosis fungoides and pleomorphic T-cell lymphoma and is likely to be an autocrine growth factor in vivo.
    Asadullah K; Haeussler A; Friedrich M; Siegling A; Olaizola-Horn S; Trefzer U; Volk HD; Sterry W
    Arch Dermatol Res; 1996 Dec; 289(1):9-13. PubMed ID: 9017129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Various cytokines modulate ICAM-1 shedding on melanoma- and CTCL-derived cell lines: inverse regulation of ICAM-1 shedding in a Sézary cell line by interferon-gamma.
    Dummer R; Sigg-Zemann S; Kalthof K; Muletta S; Meyer JC; Burg G
    Dermatology; 1994; 189(2):120-4. PubMed ID: 7915555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulated synthesis of intracellular type 1 and type 2 cytokines by T cells of patients with cutaneous T-cell lymphoma.
    Lee BN; Duvic M; Tang CK; Bueso-Ramos C; Estrov Z; Reuben JM
    Clin Diagn Lab Immunol; 1999 Jan; 6(1):79-84. PubMed ID: 9874668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile.
    Saed G; Fivenson DP; Naidu Y; Nickoloff BJ
    J Invest Dermatol; 1994 Jul; 103(1):29-33. PubMed ID: 8027577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour-specific cytotoxic T lymphocyte activity in Th2-type Sézary syndrome: its enhancement by interferon-gamma (IFN-gamma) and IL-12 and fluctuations in association with disease activity.
    Seo N; Tokura Y; Matsumoto K; Furukawa F; Takigawa M
    Clin Exp Immunol; 1998 Jun; 112(3):403-9. PubMed ID: 9649208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-7 receptor expression in cutaneous T-cell lymphomas.
    Bagot M; Charue D; Boulland ML; Gaulard P; Revuz J; Schmitt C; Wechsler J
    Br J Dermatol; 1996 Oct; 135(4):572-5. PubMed ID: 8915148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th1 response and cytotoxicity genes are down-regulated in cutaneous T-cell lymphoma.
    Hahtola S; Tuomela S; Elo L; Häkkinen T; Karenko L; Nedoszytko B; Heikkilä H; Saarialho-Kere U; Roszkiewicz J; Aittokallio T; Lahesmaa R; Ranki A
    Clin Cancer Res; 2006 Aug; 12(16):4812-21. PubMed ID: 16914566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased interleukin 5 production in eosinophilic Sézary syndrome: regulation by interferon alfa and interleukin 12.
    Suchin KR; Cassin M; Gottleib SL; Sood S; Cucchiara AJ; Vonderheid EC; Rook AH
    J Am Acad Dermatol; 2001 Jan; 44(1):28-32. PubMed ID: 11148473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma.
    Kleinhans M; Tun-Kyi A; Gilliet M; Kadin ME; Dummer R; Burg G; Nestle FO
    Blood; 2003 Feb; 101(4):1487-93. PubMed ID: 12393570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD164 identifies CD4
    Benoit BM; Jariwala N; O'Connor G; Oetjen LK; Whelan TM; Werth A; Troxel AB; Sicard H; Zhu L; Miller C; Takeshita J; McVicar DW; Kim BS; Rook AH; Wysocka M
    Arch Dermatol Res; 2017 Jan; 309(1):11-19. PubMed ID: 27766406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of IL-32 in cutaneous T-cell lymphoma.
    Suga H; Sugaya M; Miyagaki T; Kawaguchi M; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    J Invest Dermatol; 2014 May; 134(5):1428-1435. PubMed ID: 24226419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.
    Edelson RL
    J Am Acad Dermatol; 1980 Feb; 2(2):89-106. PubMed ID: 6988470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.